Related references
Note: Only part of the references are listed.Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
Eric S. Daar et al.
ANNALS OF INTERNAL MEDICINE (2011)
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naive HIV-1-infected patients
S. M. E. Vrouenraets et al.
HIV MEDICINE (2011)
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
Amanda Mocroft et al.
AIDS (2010)
Endothelial Dysfunction and Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients
Francesco Perticone et al.
CIRCULATION (2010)
Renal Hyperfiltration and Arterial Stiffness in Humans With Uncomplicated Type 1 Diabetes
David Z. I. Cherney et al.
DIABETES CARE (2010)
The clinical significance of hyperfiltration in diabetes
G. Jerums et al.
DIABETOLOGIA (2010)
Renal toxicity associated with tenofovir use
Sonia Rodriguez-Novoa et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities
Leal C. Herlitz et al.
KIDNEY INTERNATIONAL (2010)
Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension
Rebecca Hanratty et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
Weerawat Manosuthi et al.
AIDS RESEARCH AND THERAPY (2010)
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease
Robert C. Kalayjian et al.
AIDS (2008)
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy
Miguel Goicoechea et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-Infected individuals: A tale of two races
Gregory M. Lucas et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients
J. J. Kiser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies
Simone Schmid et al.
VIRCHOWS ARCHIV (2007)
Chronic renal failure among HIV-1-infected patients
Amanda Mocroft et al.
AIDS (2007)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
Antiretrovirals induce direct endothelial dysfunction in vivo
Bo Jiang et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Urinary NO3 excretion and renal failure in indinavir-treated patients
M. Eira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Low glomerular filtration in the population: Prevalence, associated disorders, and awareness
M. Cirillo et al.
KIDNEY INTERNATIONAL (2006)
HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy
J Röling et al.
CLINICAL INFECTIOUS DISEASES (2006)
Comparisons of causes of death and mortality rates among HIV-infected persons - Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras
NF Crum et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Demographics of HIV-1 infection in Denmark: Results from the Danish HIV cohort study
N Lohse et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2005)
Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease
AD Rule et al.
ANNALS OF INTERNAL MEDICINE (2004)
Hospital-onset infections: A patient safety issue
JR Johnson
ANNALS OF INTERNAL MEDICINE (2003)
Share Paper
